MCM
SUPN icon

McKinley Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

McKinley Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,102
Closed -$39K – 278
2019
Q1 		$39K Hold
1,102
– – ﹤0.01% 251
2018
Q4 		$37K Sell
1,102
-1,238
-53% -$53.2K ﹤0.01% 254
2018
Q3 		$118K Sell
2,340
-199
-8% -$9.83K 0.01% 244
2018
Q2 		$152K Sell
2,539
-177
-7% -$9.17K 0.01% 238
2018
Q1 		$124K Sell
2,716
-75,870
-97% -$3.17M 0.01% 246
2017
Q4 		$3.13M Buy
78,586
+55
+0.1% +$2.17K 0.16% 115
2017
Q3 		$3.14M Sell
78,531
-55,191
-41% -$2.39M 0.13% 125
2017
Q2 		$5.76M Sell
133,722
-41,518
-24% -$1.48M 0.22% 72
2017
Q1 		$5.49M Buy
175,240
+70
+0% +$1.88K 0.2% 78
2016
Q4 		$4.42M Sell
175,170
-140,274
-44% -$3.13M 0.17% 107
2016
Q3 		$7.8M Sell
315,444
-102,454
-25% -$2.32M 0.28% 91
2016
Q2 		$8.51M Sell
417,898
-39,437
-9% -$700K 0.41% 74
2016
Q1 		$6.97M Buy
457,335
+92,541
+25% +$1.21M 0.34% 83
2015
Q4 		$4.9M Buy
364,794
+251
+0.1% +$3.88K 0.23% 119
2015
Q3 		$5.12M Sell
364,543
-241
-0.1% -$4.48K 0.25% 115
2015
Q2 		$6.19M Buy
+364,784
New +$5.19M 0.27% 116

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

McKinley Capital Management's SUPN Position: Q2 2019 in Review

McKinley Capital Management sold out of Supernus Pharmaceuticals (SUPN) in Q2 2019, closing a stake of 1,102 shares — an estimated $39K sold.

McKinley Capital Management first reported a position in SUPN in Q2 2015 and held it in 16 quarters. The position peaked at $8.51M in Q2 2016. 272 funds tracked by Wall St. Rank hold SUPN as of Q2 2019.

  • McKinley Capital Management reported no remaining Supernus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • McKinley Capital Management sold 1,102 Supernus Pharmaceuticals shares in Q2 2019, an estimated $39K.
  • McKinley Capital Management first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 16 quarters.
  • McKinley Capital Management's Supernus Pharmaceuticals position peaked at $8.51M in Q2 2016.
  • 272 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2019.

Based on McKinley Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.